Macquarie Group
IMVT icon

Macquarie Group’s Immunovant IMVT Stock Holding History

Macquarie Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-122,100
Closed -$1.97M – 1158
2025
Q3 		$1.97M Hold
122,100
– – ﹤0.01% 1174
2025
Q2 		$1.95M Hold
122,100
– – ﹤0.01% 1235
2025
Q1 		$2.09M Hold
122,100
– – ﹤0.01% 1210
2024
Q4 		$3.02M Sell
122,100
-63,884
-34% -$1.81M ﹤0.01% 1070
2024
Q3 		$5.3M Buy
185,984
+63,884
+52% +$1.88M 0.01% 951
2024
Q2 		$3.22M Buy
122,100
+19,000
+18% +$540K ﹤0.01% 1087
2024
Q1 		$3.33M Buy
103,100
+62,474
+154% +$2.28M ﹤0.01% 1079
2023
Q4 		$1.71M Buy
+40,626
New +$1.49M ﹤0.01% 1269
2022
Q4 		– Sell
-243
Closed -$7K – 1936
2022
Q3 		$7K Sell
243
-977
-80% -$4.78K ﹤0.01% 2407
2022
Q2 		$5K Hold
1,220
– – ﹤0.01% 2526
2022
Q1 		$7K Hold
1,220
– – ﹤0.01% 2554
2021
Q4 		$10K Sell
1,220
-2,803
-70% -$23.1K ﹤0.01% 2512
2021
Q3 		$35K Sell
4,023
-50,351
-93% -$454K ﹤0.01% 2329
2021
Q2 		$575K Buy
54,374
+3,334
+7% +$46.6K ﹤0.01% 1679
2021
Q1 		$819K Buy
51,040
+29,980
+142% +$791K ﹤0.01% 1440
2020
Q4 		$973K Sell
21,060
-1,598
-7% -$73.9K ﹤0.01% 1316
2020
Q3 		$798K Buy
22,658
+21,757
+2,415% +$654K ﹤0.01% 1294
2020
Q2 		$22K Sell
901
-2,307
-72% -$49.4K ﹤0.01% 2141
2020
Q1 		$50K Buy
+3,208
New +$48.3K ﹤0.01% 1813

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Macquarie Group's IMVT Position: Q4 2025 in Review

Macquarie Group sold out of Immunovant (IMVT) in Q4 2025, closing a stake of 122,100 shares — an estimated $1.97M sold.

Macquarie Group first reported a position in IMVT in Q1 2020 and held it in 19 quarters. The position peaked at $5.3M in Q3 2024. 197 funds tracked by Wall St. Rank hold IMVT as of Q4 2025.

  • Macquarie Group reported no remaining Immunovant position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 122,100 Immunovant shares in Q4 2025, an estimated $1.97M.
  • Macquarie Group first reported a position in Immunovant in Q1 2020 and held it in 19 quarters.
  • Macquarie Group's Immunovant position peaked at $5.3M in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Immunovant as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.